I’ve always been fascinated by how life’s unexpected turns can teach us lessons that extend beyond their immediate context. In my dual roles as an IVF specialist and an angel investor, I’ve often found that one domain complements the other in surprising ways. A recent event in my IVF practice made me rethink my investment strategy, and I believe it’s worth sharing.
A patient of mine, let’s call her Neha, came in last month. She had been trying to conceive for several years and had already gone through multiple failed IVF cycles. Her determination was palpable, yet there was an underlying fatigue that mirrored the weariness of a startup founder who had pitched unsuccessfully to countless investors. Facing a low ovarian reserve, her chances were slim, but as I’ve learned over the years, slim doesn’t mean zero.
In Neha’s case, her last cycle yielded only one viable egg. The odds were stacked against her, much like a startup with just enough capital to make it through another month. But as fate would have it, that single egg split, resulting in identical twins. This wasn’t just a medical anomaly; it was a profound reminder of the potential that lies in the singular, the unexpected, the seemingly inconsequential.
This experience made me reassess my approach to investing. Much like in IVF, where each cycle and each egg carries its own set of probabilities, each startup carries unique potential and risks. Just because an opportunity seems small or unlikely doesn’t mean it’s devoid of value. In fact, sometimes the smallest investments can yield the most significant returns.
In the world of investing, particularly angel investing, we often talk about diversifying the portfolio to mitigate risk. It’s a sound strategy, akin to how we manage patient care by exploring multiple treatment options. However, Neha’s story reminded me that while diversification is crucial, so is recognizing and nurturing the potential of what seems like a long shot.
In my practice, I’ve seen many cases where the odds were not in the patient’s favor, yet they succeeded. This has taught me to look beyond the numbers and statistics and to see the human element in every situation. Similarly, in investing, I’ve learned to look beyond the balance sheets and business models to see the passion and resilience of the founder. The parallels are striking. In both fields, the journey is fraught with uncertainty, and the outcomes are never guaranteed. Yet, it is the journey itself—the perseverance, the hope, the ability to adapt—that often determines success.
In IVF, as in startups, we must prepare for setbacks. The path to success is rarely linear. Neha’s journey to motherhood was not without its heartaches. Similarly, the startups I invest in often face pivots and failures before they find their footing. What carries them through is a combination of grit, support, and a willingness to learn from every setback.
This brings me to the concept of resilience, which I believe is the cornerstone of success in both fertility treatments and startups. Resilience is not just about enduring hardships; it’s about learning from them. It’s about using past failures as stepping stones to future successes. I’ve seen patients who, after multiple failed cycles, finally hold their babies. I’ve also seen startups that, after numerous pivots, finally find their market fit.
Another lesson from Neha’s case is the importance of transparent conversations. In both IVF and investing, clear communication is crucial. It’s about setting realistic expectations, being open about risks, and celebrating small victories along the way. As I always tell my patients, and the founders I back, the journey is as important as the destination.
In the realm of IVF, transparency helps patients make informed decisions about their treatment options. In the world of investing, transparency fosters trust between investors and founders, enabling them to work collaboratively towards a common goal. This is why I strongly advocate for honest conversations in both domains.
Reflecting on Neha’s story, it becomes evident that sometimes, the most unexpected outcomes lead to the most profound insights. Her journey reinforced my belief in the power of hope and perseverance. It reminded me that in both life and business, the smallest seeds can yield the most bountiful harvests.
As an investor, I am now more inclined to take calculated risks on the ‘one-egg’ startups—the ones that may not have a plethora of resources or a proven track record but have a unique potential waiting to be unlocked. As a doctor, I am reminded to never underestimate the power of a single egg, a single chance, or a single opportunity.
Ultimately, whether it’s in the clinic or the boardroom, it’s about recognizing the potential for growth and transformation, even when the odds are not in your favor. It’s about nurturing that potential with care, patience, and unwavering belief. And sometimes, just sometimes, you end up with a miracle—or two.